Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Gearry

Showing results (1-10 of 244) with videos related to

Pageof 25
Sort By:
Digestive Diseases (Basel, Switzerland)|March 17, 2016
IBD and Environment: Are There Differences between East and WestRichard B Gearry
Journal of Gastroenterology and Hepatology|June 9, 2016
Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select?Richard B Gearry
Journal of Gastroenterology and Hepatology|June 9, 2016
IntroductionRichard B Gearry
Journal of Gastroenterology and Hepatology|March 19, 2016
Treat to target-what is realistic in Australian practice today?Richard B Gearry
Advances in Food and Nutrition Research|February 12, 2013
Kiwifruit modulation of gastrointestinal motilityLynley Drummond, Richard B Gearry
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?Dali Fan, Richard B Gearry
Inflammatory Bowel Diseases|June 13, 2020
Smoking Cessation for Patients With Crohn Disease: Not Just for the Patient?Rhys A John, Richard B Gearry
Journal of Gastroenterology and Hepatology|February 23, 2012
Rescue therapy for steroid refractory acute severe ulcerative colitis: more choice, better outcomes?Richard B Gearry, James D Falvey
Journal of Gastroenterology and Hepatology|July 29, 2005
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel diseaseRichard B Gearry, Murray L Barclay
Journal of Gastroenterology and Hepatology|May 31, 2016
Inflammatory bowel disease risk and the environment: Where to next?James M Fulforth, Richard B Gearry
Pageof 25

Showing results (1-10 of 244) with videos related to

Sort By:
Pageof 25
Digestive Diseases (Basel, Switzerland)|March 17, 2016
IBD and Environment: Are There Differences between East and WestRichard B Gearry
Journal of Gastroenterology and Hepatology|June 9, 2016
Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select?Richard B Gearry
Journal of Gastroenterology and Hepatology|June 9, 2016
IntroductionRichard B Gearry
Journal of Gastroenterology and Hepatology|March 19, 2016
Treat to target-what is realistic in Australian practice today?Richard B Gearry
Advances in Food and Nutrition Research|February 12, 2013
Kiwifruit modulation of gastrointestinal motilityLynley Drummond, Richard B Gearry
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?Dali Fan, Richard B Gearry
Inflammatory Bowel Diseases|June 13, 2020
Smoking Cessation for Patients With Crohn Disease: Not Just for the Patient?Rhys A John, Richard B Gearry
Journal of Gastroenterology and Hepatology|February 23, 2012
Rescue therapy for steroid refractory acute severe ulcerative colitis: more choice, better outcomes?Richard B Gearry, James D Falvey
Journal of Gastroenterology and Hepatology|July 29, 2005
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel diseaseRichard B Gearry, Murray L Barclay
Journal of Gastroenterology and Hepatology|May 31, 2016
Inflammatory bowel disease risk and the environment: Where to next?James M Fulforth, Richard B Gearry
Pageof 25